Turkish Version of the Ankle Fracture Outcome of Rehabilitation Measure (A-FORM-TR): A Multi-Centre Validation Study (A-FORM-TR)
Cross-Cultural Adaptation and Psychometric Validation of the Turkish Version of the Ankle Fracture Outcome of Rehabilitation Measure (A-FORM-TR): A Multi-Centre Prospective Observational Study
調査の概要
詳細な説明
Background and Rationale: Ankle fractures are among the most common lower-limb injuries in orthopedic practice. Patient-reported recovery, including physical function, sleep, mood, and social participation, is not adequately captured by traditional clinician-based outcome measures such as the AOFAS Ankle-Hindfoot Score or the Olerud-Molander Ankle Score. The A-FORM, developed by McPhail et al. (2014), is a 15-item, Rasch-calibrated patient-reported outcome measure designed specifically to evaluate the rehabilitation experience after ankle fracture. No validated Turkish-language version currently exists.
Methodological Framework: The study follows the eight-stage cross-cultural adaptation and validation protocol described by Cruchinho et al. (2024), which incorporates the recommendations of Beaton et al. (2000) and the COSMIN framework (Mokkink et al., 2010). Written permission to translate and use the instrument has been granted by Prof. Steven McPhail (Queensland University of Technology).
Translation and Adaptation: Forward translation is carried out by two independent bilingual translators (one faculty member from the Department of English Language and Literature, providing linguistic expertise; one bilingual orthopedic surgeon, providing clinical content expertise). A reconciliation committee produces a synthesised Turkish version, which is then back-translated by two independent translators blinded to the original. A harmonisation expert committee compares the source, forward, and back versions for semantic, idiomatic, experiential, and conceptual equivalence. The harmonised pre-test version is evaluated through cognitive debriefing interviews with 10 to 15 ankle-fracture patients before field testing.
Field Testing: In the field testing phase, 150 adult patients with a radiographically confirmed unilateral ankle fracture (Weber A, B, or C; treated surgically by open reduction and internal fixation or conservatively with cast, walker boot, or functional brace) are enrolled across three orthopedic centres. Patients between 3 weeks and 12 months post-injury are eligible. The A-FORM-TR is administered together with the AOFAS Ankle-Hindfoot Score and the OMAS-TR. A sub-cohort of approximately 50 patients is re-administered the A-FORM-TR at 7 to 14 days, with a Global Rating of Change item used to identify clinically stable patients for the test-retest reliability analysis.
Statistical Analysis Plan: The analysis plan was locked before any field data were collected; all decision rules are pre-specified. Developed in consultation with the institutional biostatistics team. Internal consistency is assessed by Cronbach's alpha (target greater than or equal to 0.80). Test-retest reliability is assessed by the intraclass correlation coefficient on stable patients, reported with the K-index (greater than or equal to 0.70 acceptable for group-level comparison, greater than or equal to 0.90 desirable for individual-level decisions). Measurement error is evaluated separately from reliability as the standard error of measurement and the smallest detectable change. Rasch measurement analysis is the primary framework and examines item fit, threshold ordering, person separation reliability, person-item targeting, local independence, unidimensionality, and differential item functioning by sex, age group, treatment modality, recruiting centre, and time since injury; pre-specified decision rules govern the handling of item misfit, disordered thresholds and differential item functioning. Confirmatory factor analysis provides a complementary structural test of the prespecified single-factor model, with exploratory factor analysis run as a supplementary check. Construct validity is assessed via pre-specified hypotheses about correlation patterns with the AOFAS and OMAS-TR, and by known-groups comparison across time-since-injury strata. Criterion validity is assessed in a bilingual sub-study of approximately 30 participants completing both the A-FORM-TR and the original English-language A-FORM in counterbalanced order, with agreement quantified by correlation, intraclass correlation and Bland-Altman analysis. Responsiveness is assessed at 3 months against a Global Rating of Change anchor using the standardised response mean (SRM), effect size and receiver operating characteristic (ROC) analysis, with the minimal important change compared against the smallest detectable change. Cross-cultural measurement invariance is examined against the original English calibration, conditional on the source data available from the instrument developer. Content validity is assessed via item-level and scale-level Content Validity Index and the Kappa coefficient from the expert committee. Floor and ceiling effects are examined at the scale level. Missing data are reported per item; the primary analysis is complete-case, with multiple imputation as a sensitivity analysis where item-level missingness exceeds 5 percent.
研究の種類
入学 (推定)
連絡先と場所
研究連絡先
- 名前:Utku Gurhan, MD
- 電話番号:+90 539 112 6898
- メール:utkugrhn@gmail.com
研究場所
-
-
-
Kyrenia、キプロス
- 募集
- University of Kyrenia, Dr. Suat Gunsel Hospital - Department of Orthopaedics and Traumatology
-
コンタクト:
- Utku Gurhan, MD
- メール:utkugrhn@gmail.com
-
主任研究者:
- Utku Gurhan, MD
-
Nicosia、キプロス
- 募集
- Near East University Hospital - Department of Orthopaedics and Traumatology
-
副調査官:
- Enes Sari, MD
-
-
-
-
Cankara
-
Ankara、Cankara、トルコ(Türkiye)、6600
- 募集
- Ankara Bilkent City Hospital - Department of Orthopaedics and Traumatology
-
コンタクト:
- Yakup Kahve, MD
- メール:ykahve@hotmail.com
-
副調査官:
- Yakup Kahve, MD
-
-
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
サンプリング方法
調査対象母集団
説明
Inclusion Criteria:
- Age 18 years or older
- Radiographically confirmed unilateral ankle fracture (Weber A, B, or C)
- Either surgical (open reduction and internal fixation) or conservative (cast, walker boot, or functional brace) treatment completed
- Currently in the rehabilitation phase, 3 weeks to 12 months post-injury
- Native Turkish speaker, able to read and self-complete a questionnaire
- Able and willing to provide written informed consent
Exclusion Criteria:
- Bilateral ankle fracture
- Previous ipsilateral ankle fracture or any prior orthopedic surgery on the same ankle
- Pathological fracture (tumour, metastasis, or other underlying bone pathology)
- Concurrent significant ipsilateral lower-limb injury (for example pilon fracture, ipsilateral tibial or fibular shaft fracture, ipsilateral femoral or tibial plateau fracture)
- Polytrauma (significant head, spine, abdominal, or contralateral lower-limb injury affecting function)
- Cognitive or psychiatric impairment precluding self-completion of the questionnaire
- Insufficient Turkish literacy
- Inability to attend a follow-up visit for the test-retest assessment
研究計画
研究はどのように設計されていますか?
デザインの詳細
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Internal consistency of the A-FORM-TR
時間枠:At the single study visit (baseline administration)
|
Cronbach's alpha coefficient calculated across all scored items of the A-FORM-TR.
Target greater than or equal to 0.80.
|
At the single study visit (baseline administration)
|
|
Test-retest reliability of the A-FORM-TR
時間枠:Second administration at day 7 and third administration at day 14 after baseline
|
Intraclass correlation coefficient (two-way mixed effects, absolute agreement, single measures) calculated for the A-FORM-TR Summary Score, restricted to patients reporting clinical stability (no change) on a Global Rating of Change item.
The K-index of agreement is reported alongside the ICC.
Thresholds: greater than or equal to 0.70 acceptable for group-level comparison; greater than or equal to 0.90 desirable for individual-level decisions.
|
Second administration at day 7 and third administration at day 14 after baseline
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Construct validity assessed by a priori hypothesis testing
時間枠:At the single study visit (baseline administration)
|
Pearson or Spearman correlations between the A-FORM-TR Summary Score and the AOFAS Ankle-Hindfoot Score and OMAS-TR.
Pre-specified hypotheses: H1, strong positive correlation between A-FORM-TR and OMAS-TR (r greater than or equal to 0.60); H2, moderate positive correlation between A-FORM-TR and AOFAS (r between 0.40 and 0.60); H3, the psychosocial items of the A-FORM-TR correlate more weakly with the AOFAS than the physical-function items.
Construct validity is considered supported if at least 75 percent of the a priori hypotheses are confirmed.
|
At the single study visit (baseline administration)
|
|
Content validity of the A-FORM-TR
時間枠:Pre-testing phase, prior to field testing
|
Item-level and scale-level Content Validity Index and the Kappa coefficient of agreement derived from the expert committee evaluation conducted in the pre-testing phase.
|
Pre-testing phase, prior to field testing
|
|
Distribution properties: floor and ceiling effects
時間枠:At the single study visit (baseline administration)
|
Percentage of participants scoring at the floor (lowest possible score) and ceiling (highest possible score) of the A-FORM-TR Summary Score.
Effects are considered acceptable if less than 15 percent at either extreme.
|
At the single study visit (baseline administration)
|
|
Rasch model fit of the A-FORM-TR
時間枠:At the single study visit (baseline administration)
|
Rasch measurement analysis serves as the primary framework for evaluating dimensionality and measurement properties of the A-FORM-TR.
Examined: item fit (infit and outfit mean-square 0.5 to 1.5), category threshold ordering, person separation reliability (target greater than or equal to 2.0), local independence (residual correlations less than 0.30), unidimensionality (residual principal component analysis first contrast less than 2.0), and differential item functioning by sex, age group, treatment modality, centre, and time since injury.
A priori decision rules: items showing substantive misfit will be reviewed for rescoring or removal; disordered thresholds will trigger response category collapsing and re-analysis; items showing significant DIF will be split or removed and the analysis re-run on the modified scale.
|
At the single study visit (baseline administration)
|
|
Structural validity by confirmatory factor analysis
時間枠:At the single study visit (baseline administration)
|
Confirmatory factor analysis testing the prespecified single-factor (unidimensional) structure established in the original A-FORM development by McPhail et al. (2014).
CFA serves as a complementary structural check from a latent-variable perspective alongside the primary Rasch analysis.
Model fit assessed by CFI and TLI (target greater than or equal to 0.95), RMSEA (target less than or equal to 0.08), and SRMR (target less than or equal to 0.08).
|
At the single study visit (baseline administration)
|
|
Known-groups validity by time since injury and treatment modality
時間枠:At the single study visit (baseline administration)
|
Known-groups validity assessed by testing whether A-FORM-TR Summary Scores differ across pre-specified clinical subgroups.
Pre-specified hypotheses: H4, patients in the 3-week to 3-month post-injury subgroup will score significantly lower (greater impairment) than patients in the 6- to 12-month subgroup; H5, A-FORM-TR Summary Scores will differ between surgically treated and conservatively treated patients (no a priori directional hypothesis).
Analyses by independent-samples t-test or Mann-Whitney U as appropriate, with Cohen's d or effect size reporting.
Added in response to peer review feedback from the original instrument developer.
|
At the single study visit (baseline administration)
|
|
Measurement error of the A-FORM-TR
時間枠:Between baseline and the day 14 administration
|
Standard error of measurement (SEM) derived from the test-retest data, and the smallest detectable change (SDC) calculated as 1.96 x square root of 2 x SEM.
Bland-Altman plots with limits of agreement are reported.
Measurement error is evaluated as a property distinct from reliability, in line with the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) framework.
|
Between baseline and the day 14 administration
|
|
Responsiveness of the A-FORM-TR
時間枠:Baseline and 3 months
|
Ability of the A-FORM-TR to detect change over time, assessed against an anchor.
Change scores from baseline to 3 months are correlated with a single-item Global Rating of Change (expected r greater than or equal to 0.50).
The standardised response mean (SRM) and effect size are computed separately in patients reporting improvement and in those reporting no change (expected SRM greater than or equal to 0.80 versus less than 0.20).
Discrimination between improved and stable patients is assessed by receiver operating characteristic (ROC) analysis, with the area under the curve (AUC) expected to be greater than or equal to 0.70.
The minimal important change derived from the ROC optimal cut-point is compared against the smallest detectable change.
|
Baseline and 3 months
|
|
Criterion validity against the original English A-FORM
時間枠:Baseline (Day 1); both language versions administered in the same session, at least 30 minutes apart
|
In a bilingual sub-study of approximately 30 Turkish Cypriot participants who are functionally literate in both Turkish and English, both the A-FORM-TR and the original English-language A-FORM are administered in counterbalanced order with at least 30 minutes between administrations.
Agreement between the two language versions is assessed by Pearson or Spearman correlation (expected r greater than or equal to 0.80), intraclass correlation coefficient (expected greater than or equal to 0.80), and Bland-Altman analysis to detect systematic differences.
Bilingual eligibility requires documented criteria beyond self-report.
This subgroup is not representative of the main sample and this is reported as a limitation.
|
Baseline (Day 1); both language versions administered in the same session, at least 30 minutes apart
|
|
Cross-cultural measurement invariance
時間枠:At the single study visit (baseline administration)
|
Comparison of the Turkish item calibration against the original English-language calibration reported by McPhail et al. 2014.
The analysis is conditional on the level of source data available from the instrument developer: with raw item-level data, multi-group confirmatory factor analysis testing configural, metric and scalar invariance; with item difficulty estimates only, anchored Rasch calibration with comparison of item difficulty hierarchies.
If neither is available, within-sample differential item functioning by sex, age group, treatment modality, recruiting centre and time since injury is reported together with a descriptive comparison against the published psychometric profile.
|
At the single study visit (baseline administration)
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Utku Gurhan, MD、University of Kyrenia
出版物と役立つリンク
一般刊行物
- Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976). 2000 Dec 15;25(24):3186-91. doi: 10.1097/00007632-200012150-00014. No abstract available.
- Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, Bouter LM, de Vet HC. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res. 2010 May;19(4):539-49. doi: 10.1007/s11136-010-9606-8. Epub 2010 Feb 19.
- McPhail SM, Williams CM, Schuetz M, Baxter B, Tonks P, Haines TP. Development and validation of the ankle fracture outcome of rehabilitation measure (A-FORM). J Orthop Sports Phys Ther. 2014 Jul;44(7):488-99, B1-2. doi: 10.2519/jospt.2014.4980. Epub 2014 May 22.
- Cruchinho P, Lopez-Franco MD, Capelas ML, Almeida S, Bennett PM, Miranda da Silva M, Teixeira G, Nunes E, Lucas P, Gaspar F; Handovers4SafeCare. Translation, Cross-Cultural Adaptation, and Validation of Measurement Instruments: A Practical Guideline for Novice Researchers. J Multidiscip Healthc. 2024 May 31;17:2701-2728. doi: 10.2147/JMDH.S419714. eCollection 2024.
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- AFORM-TR-2026
- ETK26-GD-0094 (その他の識別子:Girne University Clinical Research Ethics Committee)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
IPD 共有時間枠
IPD 共有アクセス基準
IPD 共有サポート情報タイプ
- STUDY_PROTOCOL
- SAP
- ICF
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。